Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Integrating evolutionary dynamics into cancer therapy
Robert A. Gatenby, Joel S. Brown
Nature Reviews Clinical Oncology (2020) Vol. 17, Iss. 11, pp. 675-686
Closed Access | Times Cited: 165

Showing 1-25 of 165 citing articles:

The influence of evolutionary history on human health and disease
Mary Lauren Benton, Abin Abraham, Abigail L. LaBella, et al.
Nature Reviews Genetics (2021) Vol. 22, Iss. 5, pp. 269-283
Open Access | Times Cited: 226
Chemical molecular‐based approach to overcome multidrug resistance in cancer by targeting P‐glycoprotein (P‐gp)
Hang Zhang, Hai‐Wei Xu, Charles R. Ashby, et al.
Medicinal Research Reviews (2020) Vol. 41, Iss. 1, pp. 525-555
Closed Access | Times Cited: 211
Macrophages at the interface of the co-evolving cancer ecosystem
Daan J. Kloosterman, Leila Akkari
Cell (2023) Vol. 186, Iss. 8, pp. 1627-1651
Open Access | Times Cited: 190
Mesenchymal stem cell-derived exosomes in cancer therapy resistance: recent advances and therapeutic potential
Zhengjun Lin, Yanlin Wu, Yiting Xu, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 182
Cancer evolution: Darwin and beyond
Roberto Vendramin, Kevin Litchfield, Charles Swanton
The EMBO Journal (2021) Vol. 40, Iss. 18
Open Access | Times Cited: 180
P-Glycoprotein: One Mechanism, Many Tasks and the Consequences for Pharmacotherapy of Cancers
Anna Seelig
Frontiers in Oncology (2020) Vol. 10
Open Access | Times Cited: 142
Spatial omics: Navigating to the golden era of cancer research
Yingcheng Wu, Yifei Cheng, Xiangdong Wang, et al.
Clinical and Translational Medicine (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 93
Tumour immunotherapy: lessons from predator–prey theory
Phineas T. Hamilton, Bradley R. Anholt, Brad H. Nelson
Nature reviews. Immunology (2022) Vol. 22, Iss. 12, pp. 765-775
Closed Access | Times Cited: 73
Natural Coevolution of Tumor and Immunoenvironment in Glioblastoma
Lingxiang Wu, Wei Wu, Junxia Zhang, et al.
Cancer Discovery (2022) Vol. 12, Iss. 12, pp. 2820-2837
Open Access | Times Cited: 71
A survey of open questions in adaptive therapy: Bridging mathematics and clinical translation
Jeffrey West, Fred Adler, Jill Gallaher, et al.
eLife (2023) Vol. 12
Open Access | Times Cited: 43
Impact of cancer metabolism on therapy resistance – Clinical implications
Ana Cristina Gonçalves, Elena Richiardone, Joana Jorge, et al.
Drug Resistance Updates (2021) Vol. 59, pp. 100797-100797
Open Access | Times Cited: 90
Identifying key questions in the ecology and evolution of cancer
Antoine M. Dujon, Athena Aktipis, Catherine Alix‐Panabières, et al.
Evolutionary Applications (2020) Vol. 14, Iss. 4, pp. 877-892
Open Access | Times Cited: 76
A theoretical analysis of tumour containment
Yannick Viossat, Robert Noble
Nature Ecology & Evolution (2021) Vol. 5, Iss. 6, pp. 826-835
Open Access | Times Cited: 72
Gemcitabine cationic polymeric nanoparticles against ovarian cancer: formulation, characterization, and targeted drug delivery
Sankha Bhattacharya, Md Meraj Anjum, Krishna Kumar Patel
Drug Delivery (2022) Vol. 29, Iss. 1, pp. 1060-1074
Open Access | Times Cited: 46
3D cancer models: One step closer to in vitro human studies
Nicoletta Manduca, Ester Maccafeo, Ruggero De Maria, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 40
The future of evolutionary medicine: sparking innovation in biomedicine and public health
Barbara Natterson-Horowitz, Athena Aktipis, Molly Fox, et al.
Frontiers in Science (2023) Vol. 1
Open Access | Times Cited: 32
Da-Chai-Hu-Tang Formula inhibits the progression and metastasis in HepG2 cells through modulation of the PI3K/AKT/STAT3-induced cell cycle arrest and apoptosis
Zi-Wei Duan, Yong Liu, Peipei Zhang, et al.
Journal of Ethnopharmacology (2024) Vol. 331, pp. 118293-118293
Closed Access | Times Cited: 9
Adaptive Treatment of Metastatic Prostate Cancer Using Generative Artificial Intelligence
Youcef Derbal
Clinical Medicine Insights Oncology (2025) Vol. 19
Open Access | Times Cited: 1
Computational Nuclear Oncology Toward Precision Radiopharmaceutical Therapies: Current Tools, Techniques, and Uncharted Territories
Tahir Yusufaly, Emilie Roncali, Julia Brosch-Lenz, et al.
Journal of Nuclear Medicine (2025), pp. jnumed.124.267927-jnumed.124.267927
Closed Access | Times Cited: 1
Cancer cells employ an evolutionarily conserved polyploidization program to resist therapy
Kenneth J. Pienta, Emma U. Hammarlund, Robert H. Austin, et al.
Seminars in Cancer Biology (2020) Vol. 81, pp. 145-159
Open Access | Times Cited: 66
Engineered exosomes in emerging cell-free therapy
Chaohua Si, Jianen Gao, Xu Ma
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 8
To modulate or to skip: De-escalating PARP inhibitor maintenance therapy in ovarian cancer using adaptive therapy
Maximilian Strobl, Alexandra Martin, Jeffrey West, et al.
Cell Systems (2024) Vol. 15, Iss. 6, pp. 510-525.e6
Closed Access | Times Cited: 8
The Evolution and Ecology of Resistance in Cancer Therapy
Robert A. Gatenby, Joel S. Brown
Cold Spring Harbor Perspectives in Medicine (2020) Vol. 10, Iss. 11, pp. a040972-a040972
Open Access | Times Cited: 41
DNA-Binding Anticancer Drugs: One Target, Two Actions
Bruce C. Baguley, Catherine J. Drummond, Ying Yi Chen, et al.
Molecules (2021) Vol. 26, Iss. 3, pp. 552-552
Open Access | Times Cited: 34
Regulation of Tumor Invasion by the Physical Microenvironment: Lessons from Breast and Brain Cancer
Garrett F. Beeghly, Kwasi Yeboa Amofa, Claudia Fischbach, et al.
Annual Review of Biomedical Engineering (2022) Vol. 24, Iss. 1, pp. 29-59
Open Access | Times Cited: 27
Page 1 - Next Page

Scroll to top